Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected lower-extremity deep venous thrombosis.
D000925:Anticoagulants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004636:Emergency Service, Hospital; D005338:Fibrin Fibrinogen Degradation Products; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D016134:Organizational Policy; D011379:Prognosis; D020246:Venous Thrombosis / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy
D000925:Anticoagulants; D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D; D006493:Heparin